Emergence of peripheral CD3+CD56+ cytokine-induced killer cell in HIV-1-infected Chinese children

International Immunology

Volumn 24, Issue 3, 2012, Pages 197-206

  Fu, Geng Feng ^a   Chen, Xu ^b   Hu, Hai Yang ^a   Yang, Hai Tao ^a   Xu, Xiao Qin ^a   Qiu, Tao ^a   Li, Lei ^a   Xu, Jin Shui ^a   Huan, Xi Ping ^a   Hou, Ya Yi ^b  

^a JIANGSU PROVINCIAL CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

HIV 1; Mother to child transmission; Receptor

Indexed keywords

CD16 ANTIGEN; CD3 ANTIGEN; CD56 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 3DL1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2D; NKP80 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CELL FUNCTION; CELL MATURATION; CHILD; CHINESE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE INDUCED KILLER CELL; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE TRANSMISSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD;

EID: 84863298339     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr124     Document Type: Article

References (35)

1. Gao, X., Nelson, G. W., Karacki, P. et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344:1668.
2. Little, A. M. and Parham, P. 1999. Polymorphism and evolution of HLA class I and II genes and molecules. Rev. Immunogenet. 1:105.
3. Polycarpou, A., Ntais, C., Korber, B. T. et al. 2002. Association between maternal and infant class I and II HLA alleles and of their concordance with the risk of perinatal HIV type I transmission. AIDS Res. Hum. Retroviruses 18:741.
4. Vilches, C. and Parham, P. 2002. KIR diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20:217.
5. Akagi, J., Takai, E., Tamori, Y. and Ogawa, M. 2001. CD3+CD56+CD8+cells demonstrating a suppressor T cell-like function in the peripheral blood of colon cancer patients. Int. J. Oncol. 19:561.
6. Barcelos, W., Sathler-Avelar, R., Martines-Filho, O. A. et al. 2008. Natural killer cell subpopulations in putative resistant individuals and patients with Mycobacterium tuberculosis infection. Scand. J. Immunol. 68:92.
7. Pernollet, M., Jouvin-Marche, E., Leroy, V., Vigan, I., Zarski, J. P. and Marche, P. N. 2002. Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV-infected patients: relationship with histological lesions. Clin. Exp. Immunol. 130:518.
8. Talal, A. H., Shata, M. T., markatou, M. et al. 2004. Virus dynamics and immune responses during treatment in patients coinfected with Hepatitis C and HIV. J. Acquir. Immune Defic. Syndr. 35:103.
9. Linn, Y. C., Wang, S. M. and Hui, K. M. 2005. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acted lymphoblastic leukemic stimulators using oligonucleotide arrays. Exp. Hematol. 33:671.
10. Feng, W., Cai, B. and Wang, L. 2007. Research on clinical significance of CD3+CD56+ NKTcells and CD3-CD56+ NK cells in patients with malignant tumors. Chin. J. Lung Cancer 10:429.
11. Doherty, D. G., Norris, S., Madrigal-Estebas, L. et al. 1999. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokines secretion patterns. J. Immunol. 163:2314.
12. Kishi, Y., Kami, M., Murashige, N. et al. 2005. Hyperacute GVHD and emergence of peripheral CD3+CD56+ T cells and activated natural killer cells are useful markers for early diagnosis of posttransplant hemophagocytic syndrome. Bone Marrow Transpl. 35:415.
13. Linn, Y. C., Wang, S. M. and Hui, K. M. 2005. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays. Exp. Hematol. 33:671.
14. Lu, P. H. and Negrin, R. S. 1994. A novel population of expanded human CD3+ CD56+ cells derived from T cells with potent in vivo anti-tumor activity in mice with several combined immunodeficiency. J. Immonol. 153:1687.
15. Bollard, C. M., Aguilar, L., Straathof, K. C. et al. 2004. Cytotoxic T lymphocyte therapy for Epstein-Barr virus+ Hodgkin's disease. J. Exp. Med. 200:1623.
16. Comoli, P., Pedrazzoli, P., Maccario, R. et al. 2005. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. J. Clin. Oncol. 23:8942.
17. Petvises, S., Pakakasama, S., Wongkajornsilp, A., Sirireung, S., Panthangkool, W. and Hongeng, S. 2007. Ex vivo generation of cytokine-induced killer cells (CD3+ CD56+) from cell transplant pediatric patients against autologous- Epstein-Barr virus-transformed lymphoblastiod cell lines. Pediatr. Transplant. 11:511.
18. Fehniger, T. A., Herbein, G., Yu, H. et al. 1998. Natural killer cells from HIV-1+ patients produce C-C chemokines and inhibit HIV-1 infection. J. Immunol. 161:6433.
19. Levy, J. A., Scott, I. and Mackewicz, C. 2003. Protection from HIV/AIDS: the importance of innate immunity. Clin. Immunol. 108:167.
20. Kim, H. M., Kang, J. S., Lim, J. et al. 2007. Inhibition of human ovarian tumor growth by cytokine-induced killer cells. Arch. Pharm. Res. 30:1464.
21. Engel, B. C., Laws, H. J., Buttlies, B., Kahn, T., Gobel, U. and Burdach, S. E. G. 1998. Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy. Med. Pediatric. Oncol. 31:56.
22. Bamias, A., Tsiatas, M. L., Kafantari, E. et al. 2007. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance. Gynecol. Oncol. 106:75.
23. Nawarabayashi, N., Seki, S., Hatsuse, K. et al. 2000. Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma. Hepatology 32:962.
24. Fu, G. F., Hao, S., Zhao, J. L. et al. 2009. Changes in NK cell counts and receptor expressions and emergence of CD3(dim)/CD56+ cells in HIV-1 infected patients in China. Viral Immunol. 22:105.
25. Märten, A., Ziske, C., Schöttker, B. et al. 2001. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation of both populations. J. Immunother. 24:502.
26. Schmidt-Wolf, I. G., Negrin, R. S., Kiem, H. P., Blume, K. G. and Weissman, I. L. 1991. Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J. Exp. Med. 174:139.
27. Fu, G. F., Chen, X., Hao, S. et al. 2010. Differences in natural killer cell quantification and receptor profile expression in HIV-1 infected Chinese children. Cell Immunol. 265:37.
28. Schmidt-Wolf, I. G., Lefterova, P., Johnston, V. et al. 1996. Sensitivity of multidrug-resistant tumour cell lines to immunologic effector cells. Cell Immunol. 169:85.
29. Schmidt-Wolf, I. G., Lefterova, P., Johnston, V., Huhn, D., Blume, K. G. and Negrin, R. S. 1994. Propagation of large numbers of T cells with natural killer cell markers. Br. J. Haematol. 87:453.
30. Koreck, A., Surányi, A., Szöny, B. J. et al. 2002. CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin. Exp. Immunol. 127:176.
31. Vernaris, M. R., Karami, M., Baker, J., Jayaswal, A. and Negrin, R. S. 2004. Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8 T cells. Blood 103:3065.
32. Kedzierska, K. and Crowe, S. M. 2001. Cytokines and HIV-1: interactions and clinical implications. Antivir. Chem. Chemother. 12:133.
33. Osakwe, C. E., Bleotu, C., Chifiriuc, M. C. et al. 2010. TH1/TH2 cytokine levels as an indicator for disease progression in human immunodeficiency virus type 1 infection and response to antiretroviral therapy. Roum. Arch. Microbiol. Immunol. 69:24.
34. Jin, C., Zhao, Y., Zhang, F. et al. 2009. Different plasma levels of interleukins and chemokines: comparison between children and adults with AIDS in China. Chin. Med. J. 122:530.
35. Märten, A., Renoth, S., von Lilienfeld-Toal, M. et al. 2001. Enhanced lytic activity of cytokine-induced killer cells against multiple myeloma cells after co-culture with idiotype-pulsed dendritic cells. Haematologica 86:1029.